Year: 2018
Type: article
Abstract: Dementia primarily affects an individual's cognitive function and many aspects of life are negatively affected by cognitive decline. There are no approved disease-modifying drugs and no approved prevention strategies for dementia; a heavy burden is placed on the individual who has dementia, their family, and society. In The Lancet Neurology, a report1 from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016 Dementia Collaborators presents estimates of dementia-related deaths, prevalence, quality of life measures, and risk factors, with the aim of documenting global patterns and providing data for research, and to guide a wide range of public health investments.
Source: The Lancet Neurology
Author: Lenore J Launer
Institutions: National Institutes of Health, National Institute on Aging
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $7,280
Award: Inflammation In Dementia
OpenAlex ID: W2903478311
